Abstract
Inflammaging refers to the low-grade systemic inflammation that occurs with aging present in chronic non-communicable diseases. MicroRNAs (miRNAs) are potential biomarkers for these diseases in older adults. This study aimed to assess the expression of 21 circulating miRNAs and their associations with inflammatory biomarkers in older adults. This cross-sectional study was performed with 200 individuals participating in ISA-Nutrition. The systemic low-grade inflammation score (SIS) was calculated from the plasma concentration of 10 inflammatory biomarkers. Circulating miRNA expression was assessed using the Fluidigm method. Wilcoxon-Mann–Whitney test was employed to determine differences in SIS among groups distributed according to sex and presence of MetS. Spearman’s correlation was used to estimate correlations among SIS, leptin levels, miRNA expression, and variables of interest. Analyses were performed using software R version 4.2.3, with a significance level of 0.05. The final sample consisted of 193 individuals with a mean age of 69.1 (SE = 0.5) years, being 64.7% individuals with metabolic syndrome (MetS). Positive correlations were observed between leptin concentration and metabolic risk factors, and leptin concentration was higher in individuals with MetS compared to those without MetS. The expression of 15 circulating miRNAs was negatively correlated with leptin concentration. GLMs showed negative associations between miRNAs (miR-15a, miR-16, miR-223, miR-363, miR-532), leptin, and/or SIS values; and only miR-21 showed positive association with SIS values. The results suggest the presence of peripheral leptin resistance associated with low-grade inflammation and plasma expression of miRNAs in older adults. These findings suggest the potential role of miRNAs as biomarkers for cardiometabolic risk.
Similar content being viewed by others
AVAILABILITY OF DATA AND MATERIALS
Not applicable.
References
Van Greevenbroek, M.M., C.G. Schalkwjk, and C.D. Stehouwer. 2013. Obesity-associated low-grade inflammation in type 2 diabetes mellitus: Causes and consequences. Netherlands Journal of Medicine 71: 174–187.
Weisberg, S.P., D. McCan, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. 2003. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of Clinical Investigation. https://doi.org/10.1172/JCI19246.
Chen, L., R. Chen, H. Wang, and F. Liang. 2015. Mechanisms Linking Inflammation to Insulin Resistance. International Journal of Endocrinology. https://doi.org/10.1155/2015/508409.
Awan, Z., and J. Genest. 2015. Inflammation modulation and cardiovascular disease prevention. European Journal of Preventive Cardiology. https://doi.org/10.1177/2047487314529350.
Franceschi, C., P. Garagnani, P. Parini, C. Giuliani, and A. Santoro. 2018. Inflammaging: A new immune–metabolic viewpoint for age-related diseases. Nature Reviews. https://doi.org/10.1038/s41574-018-0059-414.
Gems, D., and L. Partridge. 2013. Genetics of longevity in model organisms: Debates and paradigm shifts. Annual Review of Physiology. https://doi.org/10.1146/annurev-physiol-030212-183712.
López-Otín, C., M.A. Blasco, L. Partridge, M. Serrano, and G. Kroemer. 2013. The Hallmarks of Aging. Cell. https://doi.org/10.1016/j.cell.2013.05.039.
Brasil, Ministério da Saúde. 2011. Plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis (DCNT) no Brasil 2011–2022. Ministério da Saúde. Secretaria de Vigilância Epidemiológica. Brasília (DF).
Duncan, B.B., D. Chor, E.M.L. Aquino, I.M. Bensenor, J.G. Mill, M.I. Schmidt, P.A. Lotufo, A. Vigo, and S.M. Barreto. 2012. Doenças crônicas não transmissíveis no Brasil: Prioridade para enfrentamento e investigação. Revista de Saúde Pública. https://doi.org/10.1590/S0034-89102012000700017.
World Health Organization. 2018. Noncommunicable Diseases: Country Profiles 2018. [s.l: s.n.].
Scarpace, P.J., Matheny, M., Moore, R.L., and Tümer N. 2000. Impaired leptin responsiveness in aged rats. Diabetes. https://doi.org/10.2337/diabetes.49.3.431.
Canale, M.P., S. Manca di Villahermosa, G. Martino, V. Rovella, A. Noce, A. De Lorenzo, and N. Di Daniele. 2013. Obesity-related metabolic syndrome: Mechanisms of sympathetic overactivity. International Journal of Endocrinology. https://doi.org/10.1155/2013/865965.
Myers, M.G., Cowley, M.A., and Münzberg, H. Mechanisms of leptin action and leptin resistance. Annual Review of Physiology, 208. https://doi.org/10.1146/annurev.physiol.70.113006.100707.
Barba, G., Russo, O., Siani, A., Iacone, R., Farinaro, E., Gerardi, M.C., Russo, P., Della Valle, and Strazzullo, P. 2003. Plasma leptin and blood pressure in men: Graded association independent of body mass and fat pattern. Obesity Research. https://doi.org/10.1038/oby.2003.25.
Ortega, F.J., J. Mercaderm, and M, Catalánm V., Moreno-Navarrete, J.M., Pueyo, N., and Sabate, R.M. 2013. Targeting the Circulating MicroRNA Signature of Obesity. Clinical Chemistry. https://doi.org/10.1373/clinchem.2012.195776.
Rong, Y., W. Bao, Z. Shanm, J. Liu, X. Yu, S. Xia, H. Gao, X. Wang, P. Yao, F.B. Hu, and L. Liu. 2013. Increased MicroRNA-146a Levels in Plasma of Patients with Newly Diagnosed Type 2 Diabetes Mellitus. PLoS ONE. https://doi.org/10.1371/journal.pone.0073272.
Wang, Y., Y. Li, X. Wang, D. Zhang, H. Zhang, Q. Wu, Y. He, J. Wang, L. Zhang, H. Xia, J. Yan, X. Li, and H. Ying. 2013. Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight/obesity. Diabetologia. https://doi.org/10.1007/s00125-013-2996-8.
Simionescu, N., L.S. Niculescu, G.M. Sanda, D. Margina, and A.V. Sima. 2014. Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera. Molecular Biology Reports. https://doi.org/10.1007/s11033-014-3449-2.
Cruz, K.J.C., A.R.S. Oliveira, J.B.S. Morais, J.S. Severo, and D.N. Marreiro. 2017. Role of microRNAs on adipogenesis, chronic low-grade inflammation, and insulin resistance in obesity. Nutrition. https://doi.org/10.1016/j.nut.2016.10.003.
Keller, A., P. Leidinger, A. Bauer, et al. 2011. Toward the blood-borne miRNome of human diseases. Nature Methods. https://doi.org/10.1038/nmeth.1682.
Fisberg, R.M., C.H. Sales, M.M. Fontanelli, J.L. Pereira, M.C.G.P. Alves, M.M.L. Escuder, C.L.G. César, and M. Goldbaum. 2018. 2015 Health Survey of São Paulo with a focus on Nutrition: Rationale, design, and procedures. Nutrients. https://doi.org/10.3390/nu10020169.
Pan American Health Organization (PAHO). 2002. XXXVI Reunión del Comitê Asesor de Investigaciones en Salud – Encuestra Multicêntrica – Salud Beinestar y Envejecimeiento (SABE) en América Latina y el Caribe – Informe preliminar 2002 (online). http://www.opas.org/program/sabe.html. Accessed 17 March 2023.
World Health Organization (WHO). 2008. Waist Circumference and Waist-Hip Ratio 2008. World Health Organization (online). https://www.who.int/publications/i/item/9789241501491. Accessed 17 March 2023.
International Diabetes Federation. 2006. IDF Consensus Worldwide Definition of the Metabolic Syndrome. International Diabetes Federation (online). https://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html. Accessed 18 March 2023.
Geloneze, B., A.C.J. Vasques, C.F.C. Stabe, J.C. Pareja, L.E.F.P.L. Rosado, E.C. Queiroz, and M.A. Tambascia. 2009. HOMA1-IR and HOMA2-IR indexes in identifying insulin resistance and metabolic syndrome: Brazilian Metabolic Syndrome Study (BRAMS). Arquivos Brasileiros de Endocrinologia & Metabologia. https://doi.org/10.1590/S0004-27302009000200020.
Norde, M.M., R.M. Fisberg, D.M.L. Marchioni, and M.M. Rogero. 2020. Systemic low-grade inflammation-associated lifestyle, diet, and genetic factors: A population-based cross-sectional study. Nutrition. https://doi.org/10.1016/j.nut.2019.110596.
Tabung, F.K., S.A. Smith-Warner, J.E. Chavarro, K. Wu, C.S. Fuchs, F.B. Hu, A.T. Chan, W.C. Willett, and E.L. Giovannucci. 2016. Development and Validation of an Empirical Dietary Inflammatory Index. Journal of Nutrition. https://doi.org/10.3945/jn.115.228718.
Lumley, T., and A.J. Scott. 2013. Two-sample rank tests under complex sampling. Biometrika. https://doi.org/10.1093/biomet/ast027.
Lumley, T., and A.J. Scott. 2017. Fitting Regression Models to Survey Data. Statistical Science. https://doi.org/10.1214/16-STS605.
Cavanaugh, J.E., and A.A. Neath. 2019. The Akaike information criterion: Background, derivation, properties, application, interpretation, and refinements. Wiley Interdisciplinary Reviews: Computational Statistics. https://doi.org/10.1002/wics.1460.
Dziak, J.J., D.L. Coffman, S.T. Lanza, R. Li, and L.S. Jermiin. 2020. Sensitivity and specificity of information criteria. Briefings in bioinformatics. https://doi.org/10.1093/bib/bbz016.
Shieh, G. 2005. On power and sample size calculations for Wald tests in generalized linear models. Journal of Statistical Planning and Inference. https://doi.org/10.1016/j.jspi.2003.09.017.
R Core Team. 2023. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria (online). https://www.R-project.org/. Accessed 20 April 2023.
Lumley, T. 2020. "Survey: analysis of complex survey samples". R package version 4.0.
León-Pedroza, J.I., L.A. González-Tapia, E. del Olmo-Gil, D. Castellanos-Rodríguez, G. Escobedo, and A. González-Chávez. 2014. Low-grade systemic inflammation and the development of metabolic diseases: From the molecular evidence to the clinical practice. Cirugia y Cirujanos. https://doi.org/10.1016/j.circir.2015.05.041.
Sahu, A. 2004. Minireview: A hypothalamic role in energy balance with special emphasis on leptin. Endocrinology. https://doi.org/10.1210/en.2004-0032.
Steiner, A.A., and A.A. Romanovsky. 2007. Leptin: At the crossroads of energy balance and systemic inflammation. Progress in Lipid Research. https://doi.org/10.1016/j.plipres.2006.11.001.
Myers, M.G., Jr., S.B. Heymsfield, C. Haft, B.B. Kahn, M. Laughlin, R.L. Leibel, M.H. Tschöp, and J.A. Yanovski. 2012. Challenges and opportunities of defining clinical leptin resistance. Cell Metabolism. https://doi.org/10.1016/j.cmet.2012.01.002.
Hellström, L., H. Wahrenberg, K. Hruska, S. Reynisdottir, and P. Arner. 2000. Mechanisms behind gender differences in circulating leptin levels. Journal of Internal Medicine. https://doi.org/10.1046/j.1365-2796.2000.00678.x.
Mazusaki, H., Y. Ogawa, N. Isse, N. Satoh, T. Okazaki, M. Shigemoto, K. Mori, N. Tamura, K. Hosoda, and Y. Yoshimasa. 1995. Human obese gene expression: Adipocyte specific expression and regional differences in the adipose tissue. Diabetes. https://doi.org/10.2337/diab.44.7.855.
Montague, C.T., J.B. Prins, L. Sanders, J. Zhang, C.P. Sewter, J. Digby, C.D. Byrne, and S. O’Rahilly. 1998. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes. https://doi.org/10.2337/diabetes.47.9.1384.
Casabiell, X., V. Piniero, R. Peino, M. Lage, J. Camiña, R. Gallego, L.G. Vallejo, C. Dieguez, and F.F. Casanueva. 1998. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: Dexamethasone and estradiol stimulate leptin release in women, but not in men. Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.1210/jcem.83.6.4849.
Pineiro, V., X. Casabiell, R. Peinó, M. Lage, J.P. Camiña, C. Menendez, J. Baltar, C. Dieguez, and F. Casanueva. 1999. Dihydrotestosterone, stanozolol, androstenedione and dehydroepiandrosterone sulphate inhibit leptin secretion in female but not in male samples of omental adipose tissue in vitro: Lack of effect of testosterone. Journal of Endocrinology. https://doi.org/10.1677/joe.0.1600425.
Rosembaum, M., and R. Leibel. 1999. Role of gonadal steroids in the sexual dimorphism in body composition and circulating concentrations of leptin. Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.1210/jcem.84.6.5787.
López-Jaramillo, P., D. Gómez-Arbeláez, J. López-López, C. López-López, J. Martínez-Ortega, A. Gómez-Rodríguez, and S. Triana-Cubillos. 2014. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Hormone Molecular Biology and Clinical Investigation. https://doi.org/10.1515/hmbci-2013-0053.
Kumar, R., K. Mal, M.K. Razaq, M. Magsi, M.K. Memon, S. Memon, M.N. Afroz, H.F. Siddiqui, and A. Rizwan. 2020. Association of Leptin With Obesity and Insulin Resistance. Cureus. https://doi.org/10.7759/cureus.12178.
Chan, C.B., D. De Leo, J.W. Joseph, T.S. McQuaid, X.F. Ha, F. Xu, R.G. Tsushima, P.S. Pennefather, A.M. Salapatek, and M.B. Wheeler. 2001. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: Mechanism of action. Diabetes. https://doi.org/10.2337/diabetes.50.6.1302.
Sun, L.L., B.G. Jiang, W.T. Li, J.J. Zou, Y.Q. Shi, and Z.M. Liu. 2011. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Research and Clinical Practice. https://doi.org/10.1016/j.diabres.2010.11.006.
Ma, E., Y. Fu, and T. Garvey. 2018. Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans. Metabolic Syndrome and Related Disorders. https://doi.org/10.1089/met.2017.0101.
Lee, D.E., J.L. Brown, M.E. Rosa, L.A. Brown, R.A. Perry Jr., M.P. Wiggs, M.I. Nilsson, S.F. Crouse, J.D. Fluckey, T.A. Washington, and N.P. Greene. 2016. microRNA-16 Is Downregulated During Insulin Resistance and Controls Skeletal Muscle Protein Accretion. Journal of Cellular Biochemistry. https://doi.org/10.1002/jcb.25476.
Heyn, G.S., L.H. Corrêa, and K.G. Magalhães. 2020. The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2020.563816.
Sekar, D., V.I. Hairul Islam, K. Thirugnanasambantham, and S. Saravanan. 2014. Relevance of miR-21 in HIV and non-HIV-related lymphomas. Tumour Biology. https://doi.org/10.1007/s13277-014-2068-9.
Keller, P., V. Gburcik, N. Petrovic, I.J. Gallagher, J. Nedergaard, B. Cannon, and J.A. Timmons. 2011. Gene-chip studies of adipogenesis-regulated microRNAs in mouse primary adipocytes and human obesity. BMC Endocrine Disorders. https://doi.org/10.1186/1472-6823-11-7.
Guglielmi, V., M. D’Adamo, R. Menghini, M. Cardellini, P. Gentileschi, M. Federici, and P. Sbraccia. 2017. MicroRNA 21 is up-regulated in adipose tissue of obese diabetic subjects. Nutr Healthy Aging. https://doi.org/10.3233/NHA-160020.
Jeong Kim, Y., S. Jin Hwang, Y. Chan Bae, and J. Sup Jung. 2009. MiR-21 regulates adipogenic differentiation through the modulation of TGF-β signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells. https://doi.org/10.1002/stem.235.
Richart, A., X. Loyer, T. Néri, K. Howangyin, C.L. Guérin, A. Ngkelo, W. Bakker, I. Zlatanova, M. Rouanet, J. Vilar, B. Lévy, M. Rothenberg, Z. Mallat, M. Pucéat, and J.S. Silvestre. 2014. MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential. Stem Cells. https://doi.org/10.1002/stem.1789.
Lhamyani, S., A.-M. Gentile, R.M. Giráldez-Pérez, M. Feijóo-Cuaresma, S.Y. Romero-Zerbo, M. Clemente-Postigo, H. Zayed, W.O. Olivera, F.J. Bermúdez-Silva, J. Salas, C.L. Gómez, N. Hajji, G.O. Fuster, F.J. Tinahones, and R. El Bekay. 2020. Molecular Therapy - Nucleic Acids. https://doi.org/10.1101/2020.10.27.20219915.
Zhuang, G., C. Meng, X. Guo, P.S. Cheruku, L. Shi, H. Xu, and H. Li. 2012. A novel regulator of macrophage activation: MiR-223 in obesity-associated adipose tissue inflammation. Circulation. https://doi.org/10.1161/CIRCULATIONAHA.111.087817.
Wen, D., P. Qiao, and L. Wang. 2015. Circulating microRNA-223 as a potential biomarker for obesity. Obesity Research & Clinical Practice. https://doi.org/10.1016/j.orcp.2015.01.006.
Improta-Caria, A.C., Sousa, R.A.L., Roever, L., Fernandes, T., Oliveira, E.M., Aras Júnior, R., and Souza, R.S.F. 2022. MicroRNAs in type 2 diabetes mellitus: potential role of physical exercise. Reviews in Cardiovascular Medicine. https://doi.org/10.31083/j.rcm2301029.
Chakraborty, C., C.G.P. Doss, S. Bandyopadhyay, and G. Agoramoorthy. 2014. Influence of miRNA in insulin signaling pathway and insulin resistance: Micro-molecules with a major role in type-2 diabetes. Wiley Interdisciplinary Reviews. https://doi.org/10.1002/wrna.1240.
Chen, L., J. Cui, J. Hou, J. Long, C. Li, and L. Liu. 2014. A novel negative regulator of adipogenesis: MicroRNA-363. Stem Cells. https://doi.org/10.1002/stem.1549.
Linhart, H.G., K. Ishimura-Oka, F. DeMayo, T. Kibe, D. Repka, B. Poindexter, R.J. Bick, and G.J. Darlington. 2001. C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. The Proceedings of the National Academy of Sciences of the United States of America. https://doi.org/10.1073/pnas.211416898.
Tang, Q.Q., and M.D. Lane. 2012. Adipogenesis: From stem cell to adipocyte. Annual Review of Biochemistry. https://doi.org/10.1146/annurev-biochem-052110-115718.
Iacomino, G., and A. Siani. 2017. Role of microRNAs in obesity and obesity-related diseases. Genes & Nutrition. https://doi.org/10.1186/s12263-017-0577-z.
Ortega, F.J., J.M. Mercader, V. Catalán, J.M. Moreno-Navarrete, N. Pueyo, M. Sabater, J. Gómez-Ambrosi, R. Anglada, J.A. Fernández-Formoso, W. Ricart, G. Frühbeck, and J.M. Fernández-Real. 2013. Targeting the Circulating MicroRNA Signature of Obesity. Clinical Chemistry. https://doi.org/10.1373/clinchem.2012.195776.
Zhong, Z., W. Su, and H. Chen. 2021. MicroRNA-532-5p regulates oxidative stress and insulin secretion damage in high glucose-induced pancreatic β cells by downregulating the expression levels of CCND1. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2021.12433.
Taneera, J., J. Fadista, E. Ahlqvist, M. Zhang, N. Wierup, E. Renström, and L. Groop. 2013. Expression profiling of cell cycle genes in human pancreatic islets with and without type 2 diabetes. Molecular and Cellular Endocrinology. https://doi.org/10.1016/j.mce.2013.05.003.
Shen, J., and B. Zhu. 2018. Integrated analysis of the gene expression profile and DNA methylation profile of obese patients with type 2 diabetes. Molecular Medicine Reports. https://doi.org/10.3892/mmr.2018.8804.
ACKNOWLEDGEMENTS
This paper was supported by the São Paulo Research Foundation – FAPESP (Grant 2020/03104–5 | Grant 2019/22934–1 | Grant 2017/05125–7); National Council for Scientific and Technological Development – CNPq (Grant 150834/2020–9). The funding agencies’ had no role in the study design, collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.
Funding
This paper was supported by the São Paulo Research Foundation—FAPESP (Grant 2020/03104–5 | Grant 2019/22934–1); National Council for Scientific and Technological Development – CNPq (Grant 150834/2020–9). The sponsors had no role in the study design, collection, analysis, interpretation of data, writing of the report, or decision to submit the article for publication.
Author information
Authors and Affiliations
Contributions
Conceptualization: [Gabrielli Barbosa de Carvalho], [Marcelo Macedo Rogero]; Methodology: [Gabrielli Barbosa de Carvalho], [Marcelo Macedo Rogero]; Formal analysis and investigation: [Gabrielli Barbosa de Carvalho], [Flávia Mori Sarti], [Sadraque Enéas de Figueirêdo Lucena]; Writing – original draft preparation: [Gabrielli Barbosa de Carvalho]; Writing – review and editing: [Paula Nascimento Brandão-Lima], [Tanyara Baliani Payolla], [Sadraque Enéas de Figuerêdo Lucena] [Flávia Mori Sarti], [Regina Mara Fisberg], [Marcelo Macedo Rogero]. All authors have read and approved the version of the paper.
Corresponding author
Ethics declarations
Ethics Approval
This study was approved by the Research Ethics Committee of the School of Public Health of the University of São Paulo (# 49221121.4.0000.5421 and # 30848914.7.0000.5421 for Isa-Nutrition). Informed consent was obtained from all individual participants included in the study.
Competing Interests
The authors have no relevant financial or non-financial interests to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Carvalho, G.B., Brandão-Lima, P.N., Payolla, T.B. et al. Circulating MiRNAs Are Associated With Low-grade Systemic Inflammation and Leptin Levels in Older Adults. Inflammation 46, 2132–2146 (2023). https://doi.org/10.1007/s10753-023-01867-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-023-01867-6